Additionally, after the 1st vaccination, a higher proportion of patients with cirrhosis (35%) lacked detectable levels of anti-RBD-S1 compared with controls (6%) (p <0.05; Fig. 1D). This evidence concerns the gene PSMD1 and Cirrhosis.